23rd September 2022

Prestigious Fellowship For Creo Founder

The founder and chief technology officer at Creo Medical Group has been elected as a Fellow of the Royal Academy of Engineering.

Professor Chris Hancock, who has more than 25 years of experience in medical device development and founded Creo Medical (then MicroOncology Ltd) in 2003, is one of 72 figures in the field of engineering and technology to be elected to the Academy’s Fellowship.

The group comprises 60 fellows, seven international Fellows and five honorary Fellows, each of whom has made exceptional contributions to their own sector, pioneering new innovations, leading progress in business or academia, providing high level advice to government, or promoting wider understanding of engineering and technology.

In joining the Fellowship, they will add their capabilities to the Academy’s mission to harness the power of engineering to create a sustainable society and an inclusive economy for all.

Chris Hancock said: “It is a great honour to be elected to the Fellowship of the Royal Academy of Engineering, and to join a group of individuals who have contributed so much to the field. I am truly humbled and incredibly grateful for the acknowledgement and support I have received from my peers.”

Sir Jim McDonald, president of the Royal Academy of Engineering, added: “In an uncertain world, one thing is certain – engineering skills, vision and leadership will play a crucial part in addressing the escalating domestic and global challenges that we face today.

“The combined connectivity, professionalism, experience and wisdom of the new Fellows who join us today will greatly enrich the expertise and support we can provide to the government and to society in general.”